Abstract

Transition metals, such as zinc, are essential micronutrients in all organisms, but also highly toxic in excessive amounts. Heavy-metal transporting P-type (PIB) ATPases are crucial for homeostasis, conferring cellular detoxification and redistribution through transport of these ions across cellular membranes. No structural information is available for the PIB-4-ATPases, the subclass with the broadest cargo scope, and hence even their topology remains elusive. Here we present structures and complementary functional analyses of an archetypal PIB‑4‑ATPase, sCoaT from Sulfitobacter sp. NAS14-1. The data disclose the architecture, devoid of classical so-called heavy metal binding domains, and provides fundamentally new insights into the mechanism and diversity of heavy-metal transporters. We reveal several novel P-type ATPase features, including a dual role in heavy-metal release and as an internal counter ion of an invariant histidine. We also establish that the turn-over of PIB‑ATPases is potassium independent, contrasting to many other P-type ATPases. Combined with new inhibitory compounds, our results open up for efforts in e.g. drug discovery, since PIB-4-ATPases function as virulence factors in many pathogens.

Data availability

Atomic coordinates and structure factors for the sCoaT AlF4-- and BeF3--stabilized crystal structures have been deposited at the Protein Data Bank (PDB) under accession codes 7QBZ and 7QC0.

The following data sets were generated

Article and author information

Author details

  1. Christina Grønberg

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  2. Qiaoxia Hu

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  3. Dhani Ram Mahato

    Department of Chemistry, Umeå University, Umeå, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1121-7761
  4. Elena Longhin

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  5. Nina Salustros

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  6. Annette Duelli

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  7. Pin Lyu

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  8. Viktoria Bågenholm

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  9. Jonas Eriksson

    Department of Chemistry, Umeå University, Umeå, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  10. Komal Umashankar Rao

    Department of Laboratory Medicine, Lund University, Lund, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  11. Domhnall Iain Henderson

    Department of Laboratory Medicine, Lund University, Lund, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  12. Gabriele Meloni

    Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4976-1401
  13. Magnus Andersson

    Department of Chemistry, Umeå University, Umeå, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  14. Tristan Croll

    Department of Haematology, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  15. Gabriela Godaly

    Department of Laboratory Medicine, Umeå University, Umeå, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3467-1350
  16. Kaituo Wang

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  17. Pontus Gourdon

    Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    For correspondence
    pontus@sund.ku.dk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8631-3539

Funding

Novo Nordisk Fonden (NNF18SA0034956)

  • Christina Grønberg

Lundbeckfonden (R313-2019-774,R218-2016-1548,R133-A12689)

  • Pontus Gourdon

Knut och Alice Wallenbergs Stiftelse (2020.0194,2015.0131)

  • Pontus Gourdon

Carlsbergfondet (CF15-0542,2013_01_0641)

  • Pontus Gourdon

Novo Nordisk Fonden (NNF13OC0007471)

  • Pontus Gourdon

Brodrene Hartmann (A29519)

  • Pontus Gourdon

Agnes og Poul Friis Fond

  • Pontus Gourdon

Augustinus Fonden (16-1992)

  • Pontus Gourdon

Crafoord (20180652,20170818)

  • Pontus Gourdon

Per-Eric and Ulla Schyberg (38267)

  • Pontus Gourdon

Swedish Research Council (2016-04474)

  • Pontus Gourdon

The memorial foundation of manufacturer Vilhelm Pedersen and wife - and the Aarhus Wilson consortium

  • Christina Grønberg

The Independent Research Fund Denmark (9039-00273A)

  • Pontus Gourdon

China Scholarship Council

  • Qiaoxia Hu

Carl Tryggers Stiftelse för Vetenskaplig Forskning (CTS 17:22)

  • Dhani Ram Mahato

Swedish Research Council Starting Grant (2016-03610)

  • Magnus Andersson

Robert A. Welke Cancer Research Foundation (AT-1935-20170325 and AT-2073-20210327)

  • Gabriele Meloni

National Institute of General Medical Sciences (R35GM128704))

  • Gabriele Meloni

National Science Foundation (CHE- 2045984)

  • Gabriele Meloni

Swedish Heart-Lung Foundation (20200378)

  • Gabriela Godaly

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Grønberg et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,593
    views
  • 268
    downloads
  • 8
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Christina Grønberg
  2. Qiaoxia Hu
  3. Dhani Ram Mahato
  4. Elena Longhin
  5. Nina Salustros
  6. Annette Duelli
  7. Pin Lyu
  8. Viktoria Bågenholm
  9. Jonas Eriksson
  10. Komal Umashankar Rao
  11. Domhnall Iain Henderson
  12. Gabriele Meloni
  13. Magnus Andersson
  14. Tristan Croll
  15. Gabriela Godaly
  16. Kaituo Wang
  17. Pontus Gourdon
(2021)
Structure and ion-release mechanism of PIB-4-type ATPases
eLife 10:e73124.
https://doi.org/10.7554/eLife.73124

Share this article

https://doi.org/10.7554/eLife.73124

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Angel D'Oliviera, Xuhang Dai ... Jeffrey S Mugridge
    Research Article

    The SARS-CoV-2 main protease (Mpro or Nsp5) is critical for production of viral proteins during infection and, like many viral proteases, also targets host proteins to subvert their cellular functions. Here, we show that the human tRNA methyltransferase TRMT1 is recognized and cleaved by SARS-CoV-2 Mpro. TRMT1 installs the N2,N2-dimethylguanosine (m2,2G) modification on mammalian tRNAs, which promotes cellular protein synthesis and redox homeostasis. We find that Mpro can cleave endogenous TRMT1 in human cell lysate, resulting in removal of the TRMT1 zinc finger domain. Evolutionary analysis shows the TRMT1 cleavage site is highly conserved in mammals, except in Muroidea, where TRMT1 is likely resistant to cleavage. TRMT1 proteolysis results in reduced tRNA binding and elimination of tRNA methyltransferase activity. We also determined the structure of an Mpro-TRMT1 peptide complex that shows how TRMT1 engages the Mpro active site in an uncommon substrate binding conformation. Finally, enzymology and molecular dynamics simulations indicate that kinetic discrimination occurs during a later step of Mpro-mediated proteolysis following substrate binding. Together, these data provide new insights into substrate recognition by SARS-CoV-2 Mpro that could help guide future antiviral therapeutic development and show how proteolysis of TRMT1 during SARS-CoV-2 infection impairs both TRMT1 tRNA binding and tRNA modification activity to disrupt host translation and potentially impact COVID-19 pathogenesis or phenotypes.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Qian Wang, Jinxin Liu ... Qian Liu
    Research Article

    Paramyxovirus membrane fusion requires an attachment protein for receptor binding and a fusion protein for membrane fusion triggering. Nipah virus (NiV) attachment protein (G) binds to ephrinB2 or -B3 receptors, and fusion protein (F) mediates membrane fusion. NiV-F is a class I fusion protein and is activated by endosomal cleavage. The crystal structure of a soluble GCN4-decorated NiV-F shows a hexamer-of-trimer assembly. Here, we used single-molecule localization microscopy to quantify the NiV-F distribution and organization on cell and virus-like particle membranes at a nanometer precision. We found that NiV-F on biological membranes forms distinctive clusters that are independent of endosomal cleavage or expression levels. The sequestration of NiV-F into dense clusters favors membrane fusion triggering. The nano-distribution and organization of NiV-F are susceptible to mutations at the hexamer-of-trimer interface, and the putative oligomerization motif on the transmembrane domain. We also show that NiV-F nanoclusters are maintained by NiV-F–AP-2 interactions and the clathrin coat assembly. We propose that the organization of NiV-F into nanoclusters facilitates membrane fusion triggering by a mixed population of NiV-F molecules with varied degrees of cleavage and opportunities for interacting with the NiV-G/receptor complex. These observations provide insights into the in situ organization and activation mechanisms of the NiV fusion machinery.